Article info
Clinical science
Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy
- Correspondence to Dr Francine Behar-Cohen, INSERM, UMRS1138, Team 17, From Physiopathology of Ocular Diseases to Clinical Development, Université Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris 75006, France; francine.behar{at}gmail.com
Citation
Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy
Publication history
- Received July 13, 2018
- Revised September 11, 2018
- Accepted October 5, 2018
- First published October 24, 2018.
Online issue publication
July 25, 2019
Article Versions
- Previous version (24 October 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.